AI-generated summary
The authors studied transcranial photobiomodulation at 808 nm and 940 nm in a kainic acid-induced rat epilepsy model. They report lower high frequency oscillation and interictal discharge rates, milder seizure behaviors, less neuronal loss and lower caspase-3 levels compared with untreated rats. The authors note that further studies are needed to determine the mechanism and optimal parameters and to validate the findings in other models.
- Who or what was studied
- Kainic acid-induced rat model of epilepsy
- Wavelengths
- 808, 940 nm
- Limits stated in the abstract
- The study was an animal model and the abstract states that further studies are needed to elucidate the mechanism, determine optimal parameters and validate effectiveness in other epilepsy models.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 940 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Photon. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.